What is it about?

The aim of this study was to determine the levels of serum pro-brain natriuretic peptide (pro-BNP) and interleukin (IL)-6 in patients with stable chronic obstructive pulmonary disease (COPD) and to correlate these markers with health-related quality of life using the COPD assessment test

Featured Image

Why is it important?

This study revealed that with increasing severity of obstruction in patients with stable chronic obstructive pulmonary disease (COPD), both IL-6 and pro-brain natriuretic peptide (pro-BNP) increased. Of equal importance, a significant positive correlation was observed between IL-6 and pro-BNP serum levels. This increase in inflammatory markers was associated with a reduced quality of life and the severity of hypoxia. These findings indicate that lowering IL-6 and pro-BNP could be useful in the management of COPD patients.

Read the Original

This page is a summary of: The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using Chronic Obstructive Pulmonary Disease Assessment Test, Medical Principles and Practice, November 2017, Karger Publishers,
DOI: 10.1159/000484900.
You can read the full text:

Read

Contributors

The following have contributed to this page